The US Food and Drug Administration (FDA) has issued the first emergency use authorisation for a vaccine for the prevention of coronavirus (COVID-19) in individuals aged 16 and above. The emergency use authorisation allows distribution of the vaccine produced by Pfizer-BioNTech in the US.